Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”

Sonino, Nicoletta, Fava, Giovanni A. · 2002 · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Abstract

Cushing's syndrome is due to chronic glucocorticoid excess that may have various etiologies. The most common endogenous form is pituitary-dependent bilateral adrenal hyperplasia, which is termed Cushing's disease. Major depression occurs in more than half of the cases. The presence of depressive symptoms connotes severity of clinical presentation and, in patients with hypothalamic-pituitary forms, entails prognostic value. Medical treatment may be used while awaiting more definitive solutions for the illness by surgery. The inhibitors of steroid production (e.g., ketoconazole, metyrapone and aminoglutethimide), rather than antidepressant drugs, are generally successful in lifting depression as well as other disabling symptoms. Since central serotonergic regulation could have a role in the course of Cushing's disease, serotonin antagonists (e.g., cyproheptadine, ritanserin and ketanserin) have been employed. Findings related to the pharmacological response of depression in Cushing's disease were found to have implications for the pathophysiology of depression and the potential involvement of the hypothalamic-pituitary-adrenal axis (HPA axis) in resistance and tolerance to antidepressant drugs. The use of serotonergic drugs in Cushing's disease may yield important insights in the understanding of serotonergic regulation both in Cushing's disease and in the HPA axis in nonendocrine major depression.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0278-5846(02)00252-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 11

Metadata

Authors
Sonino, N., & Fava, G. A.
Affiliations
  • University of Padua (IT)
  • University of Bologna (IT)
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
2002-06
Volume
26
Issue
5
Pages
1011-1018
ISSN
0278-5846 (ISSN-L)
OpenAlex
W1992270145
Cited by
11
References
0
Citations by year
2022: 1 · 2018: 1 · 2015: 1 · 2014: 1
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministero dell'Università e della Ricerca
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
Cushing's disease, major depressive disorder, mood disorders, glucocorticoid excess, hypothalamic-pituitary-adrenal axis, antidepressant resistance, serotonergic drugs, cyproheptadine, ketoconazole, metyrapone, aminoglutethimide, steroidogenesis inhibitors, depression pathophysiology
MeSH terms
Central Nervous System Agents, Cushing Syndrome, Humans, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”. https://app.cochat.ai/papers/10.1016/s0278-5846(02)00252-x
The paper
Sonino, N., & Fava, G. A. (2002). Erratum to “CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders”. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/s0278-5846(02)00252-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.